Trial · NCT01511068
Results by group82
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 82
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Time (Minutes) to Discontinuation of Exercise During a Standardized Treadmill Exercise Test | Inhaled Leukine (rhGM-CSF) | Participant 1 | 17 | Percent Change | |
| Change in Time (Minutes) to Discontinuation of Exercise During a Standardized Treadmill Exercise Test | Inhaled Leukine (rhGM-CSF) | Participant 2 | 33 | Percent Change | |
| Change in Diffusion Capacity for Carbon Monoxide | Inhaled Leukine (rhGM-CSF) | Participant 1 | 11 | Percent Change | |
| Change in Diffusion Capacity for Carbon Monoxide | Inhaled Leukine (rhGM-CSF) | Participant 2 | 4 | Percent Change | |
| Change in Minimum Pulse Oximetry During a Standardized Exercise Protocol Oximetry | Inhaled Leukine (rhGM-CSF) | Participant 1 | 0 | Percent Change | |
| Change in Minimum Pulse Oximetry During a Standardized Exercise Protocol Oximetry | Inhaled Leukine (rhGM-CSF) | Participant 2 | 50 | Percent Change | |
| Change in Radiographic Evidence of PAP Lung Disease | Inhaled Leukine (rhGM-CSF) | Participant 1-Right Lung Baseline | -510 | Hounsfield Units | |
| Change in Radiographic Evidence of PAP Lung Disease | Inhaled Leukine (rhGM-CSF) | Participant 1- Right Lung End of Treatment | -579 | Hounsfield Units | |
| Change in Radiographic Evidence of PAP Lung Disease | Inhaled Leukine (rhGM-CSF) | Participant 1-Left Lung Baseline | -366 | Hounsfield Units | |
| Change in Radiographic Evidence of PAP Lung Disease | Inhaled Leukine (rhGM-CSF) | Participant 1-Left Lung End of Treatment | -441 | Hounsfield Units | |
| Change in Radiographic Evidence of PAP Lung Disease | Inhaled Leukine (rhGM-CSF) | Participant 2-Right Lung Baseline | -593 | Hounsfield Units | |
| Change in Radiographic Evidence of PAP Lung Disease | Inhaled Leukine (rhGM-CSF) | Participant 2-Right Lung End of Treatment | -675 | Hounsfield Units | |
| Change in Radiographic Evidence of PAP Lung Disease | Inhaled Leukine (rhGM-CSF) | Participant 2-Left Lung Baseline | -630 | Hounsfield Units | |
| Change in Radiographic Evidence of PAP Lung Disease | Inhaled Leukine (rhGM-CSF) | Participant 2-Left Lung End of Treatment | -726 | Hounsfield Units | |
| Change in Quality of Life | Inhaled Leukine (rhGM-CSF) | Participant 1 -Total Score | 10.7 | Percent Change | |
| Change in Quality of Life | Inhaled Leukine (rhGM-CSF) | Participant 1 - Physical Health Score | 75 | Percent Change | |
| Change in Quality of Life | Inhaled Leukine (rhGM-CSF) | Participant 1 - Psychosocial Score | -5.2 | Percent Change | |
| Change in Quality of Life | Inhaled Leukine (rhGM-CSF) | Participant 1 - Parent Score | 19.6 | Percent Change | |
| Change in Quality of Life | Inhaled Leukine (rhGM-CSF) | Participant 1 - Child Score | 3.1 | Percent Change | |
| Change in Quality of Life | Inhaled Leukine (rhGM-CSF) | Participant 2 - Total Score | 11.7 | Percent Change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01511068/results